A review on diverse heterocyclic compounds as the privileged scaffolds in non-steroidal aromatase inhibitors

被引:30
|
作者
Rani, Sudesh [1 ]
Raheja, Konpal [1 ]
Luxami, Vijay [1 ]
Paul, Kamaldeep [1 ]
机构
[1] Thapar Inst Engn & Technol, Sch Chem & Biochem, Patiala 147001, Punjab, India
关键词
Non-steroidal aromatase; Structure-activity relationship; Breast cancer; Heterocycles; Medicinal chemistry; BREAST-CANCER; MOLECULAR DOCKING; BIOLOGICAL CHARACTERIZATION; SELECTIVE INHIBITORS; ADJUVANT TREATMENT; ESTROGEN-RECEPTOR; HIGHLY POTENT; DERIVATIVES; TAMOXIFEN; MECHANISM;
D O I
10.1016/j.bioorg.2021.105017
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Breast cancer, emerging malignancy is common among women due to overexpression of estrogen. Estrogens are biosynthesized from androgens by aromatase, a cytochrome P450 enzyme complex, and play a pivotal role in stimulating cell proliferation. Therefore, deprivation of estrogen by blocking aromatase is considered as the effective way for the inhibition and treatment of breast cancer. In recent years, various non-steroidal heterocyclic functionalities have been extensively developed and studied for their aromatase inhibition activity. This review provides information about the structural-activity relationship of heterocycles (Type II) towards aromatase. This aids the medicinal chemist around the significance of different heterocyclic moieties and helps to design potent aromatase inhibitors.
引用
收藏
页数:27
相关论文
共 50 条
  • [41] The time since last menstrual period is important as a clinical predictor for non-steroidal aromatase inhibitor-related arthralgia
    Kanematsu, Miyuki
    Morimoto, Masami
    Honda, Junko
    Nagao, Taeko
    Nakagawa, Misako
    Takahashi, Masako
    Tangoku, Akira
    Sasa, Mitsunori
    BMC CANCER, 2011, 11 : 436
  • [42] Reduction of Breast Cancer Relapses with Perioperative Non-Steroidal Anti-Inflammatory Drugs: New Findings and a Review
    Retsky, Michael
    Demicheli, Romano
    Hrushesky, William J. M.
    Forget, Patrice
    De Kock, Marc
    Gukas, Isaac
    Rogers, Rick A.
    Baum, Michael
    Sukhatme, Vikas
    Vaidya, Jayant S.
    CURRENT MEDICINAL CHEMISTRY, 2013, 20 (33) : 4163 - 4176
  • [43] Effect of COX-2 inhibitors and other non-steroidal inflammatory drugs on breast cancer risk: a meta-analysis
    de Pedro, Maria
    Baeza, Sara
    Escudero, Maria-Teresa
    Dierssen-Sotos, Trinidad
    Gomez-Acebo, Ines
    Pollan, Marina
    Llorca, Javier
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 149 (02) : 525 - 536
  • [44] Effect of COX-2 inhibitors and other non-steroidal inflammatory drugs on breast cancer risk: a meta-analysis
    María de Pedro
    Sara Baeza
    María-Teresa Escudero
    Trinidad Dierssen-Sotos
    Inés Gómez-Acebo
    Marina Pollán
    Javier Llorca
    Breast Cancer Research and Treatment, 2015, 149 : 525 - 536
  • [45] Non-steroidal inhibitors of Drosophila melanogaster steroidogenic glutathione S-transferase Noppera-bo
    Koiwai, Kotaro
    Morohashi, Kana
    Inaba, Kazue
    Ebihara, Kana
    Kojima, Hirotatsu
    Okabe, Takayoshi
    Yoshino, Ryunosuke
    Hirokawa, Takatsugu
    Nampo, Taiki
    Fujikawa, Yuuta
    Inoue, Hideshi
    Yumoto, Fumiaki
    Senda, Toshiya
    Niwa, Ryusuke
    JOURNAL OF PESTICIDE SCIENCE, 2021, 46 (1-2) : 75 - 87
  • [46] Application of fluorine-containing non-steroidal anti-androgen compounds in treating prostate cancer
    Yang, Xiaoping
    Guan, Aiying
    JOURNAL OF FLUORINE CHEMISTRY, 2014, 161 : 1 - 10
  • [47] Inhibition of Human Transthyretin Aggregation by Non-Steroidal Anti-Inflammatory Compounds: A Structural and Thermodynamic Analysis
    Sant'Anna, Ricardo O.
    Braga, Carolina A.
    Polikarpov, Igor
    Ventura, Salvador
    Lima, Luis Mauricio T. R.
    Foguel, Debora
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (03) : 5284 - 5311
  • [48] Quantitative structure activity relationships studies of non-steroidal anti-inflammatory drugs: A review
    Asirvatham, Sahaya
    Dhokchawle, Bharat V.
    Tauro, Savita J.
    ARABIAN JOURNAL OF CHEMISTRY, 2019, 12 (08) : 3948 - 3962
  • [49] Randomized controlled trial of toremifene 120 mg compared with exemestane 25 mg after prior treatment with a non-steroidal aromatase inhibitor in postmenopausal women with hormone receptor-positive metastatic breast cancer
    Yamamoto, Yutaka
    Ishikawa, Takashi
    Hozumi, Yasuo
    Ikeda, Masahiko
    Iwata, Hiroji
    Yamashita, Hiroko
    Toyama, Tatsuya
    Chishima, Takashi
    Saji, Shigehira
    Yamamoto-Ibusuki, Mutsuko
    Iwase, Hirotaka
    BMC CANCER, 2013, 13
  • [50] Non-steroidal anti-inflammatory drugs: recent advances in the use of synthetic COX-2 inhibitors
    Ahmadi, Mohsen
    Bekeschus, Sander
    Weltmann, Klaus-Dieter
    von Woedtke, Thomas
    Wende, Kristian
    RSC MEDICINAL CHEMISTRY, 2022, 13 (05): : 471 - 496